Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 10, 2006

View Archived Issues

In vivo analysis of beta-lactamase inhibitor NXL-104

Database lock on SIMPADICO trial of Celacade

Crucell licenses STAR technology to Xoma for research

Takeda transfers BASF Takeda Vitamin shares to BASF Japan

Nippon Shinyaku grants Innovive license to NS-187 for CML

TMC-114/ritonavir POWER 2 clinical data and antiviral enhancement with Fuzeon

Preclinical profile of aminocandin presented at ICAAC

pSivida signs new evaluation agreements for new subsidiary

EpiCept completes merger with Maxim Pharmaceuticals

Phase I study to evaluate eniluracil plus 5-FU

AVI BioPharma gets allocation from 2006 defense appropriations act

ZIO-101 to begin phase I/II study in advanced melanoma

Treatment completed in pivotal TRIUMPH study of eculizumab in PNH

Xencor and Roche extend research collaboration

Gabapentin GR shows sustained pain relief without sedation

Study confirms effectiveness of synDNA vaccines in producing immunologic activity

iDESTRIN relieves signs and symptoms of dry eye syndrome in postmenopausal women

Vicuron discloses data on novel azetidine lincosamides

KCP-256: A novel glucose concentration-dependent potentiator of insulin secretion

HPW-RX2 shown to inhibit thrombin and thromboxane formation

Fast track designation for Valortim for anthrax

New approaches for HIV infection treatment disclosed in recent patent literature

New gastric acid antisecretory agents emerge from Altana R&D

Clinical data on brecanavir for HIV infection reported

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...